ExploreWatchlistsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Selling, general & administrative

ACADIA PHARMACEUTICALS INC (ACAD)

Market cap
$4.2B
P/E ratio
10.8x
SummaryFinancials
Period EndSelling, general & administrative (Million USD)YoY (%)
Dec 31, 2025549+12.38%
Dec 31, 2024488+20.14%
Dec 31, 2023407+10.15%
Dec 31, 2022369-6.80%
Dec 31, 2021396+1.90%
Dec 31, 2020389+19.35%
Dec 31, 2019326+22.53%
Dec 31, 2018266+4.19%
Dec 31, 2017255+36.79%
Dec 31, 2016186

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat